Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) France

Research

Date range: 1 August 2022 - 31 July 2023

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) published between 1 August 2022 - 31 July 2023 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)
Count Share
3 0.04

Outputs by subject (Share)

Outputs by subject
Subject Count Share
3 0.04

Share output for the past 5 years

Share per year
2018 2019 2020 2021 2022*
0.00 0.00 0.00 0.00 0.15

Compare Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) with other institutions

*Note: 2022 data contains Share for article affiliations from newly added health-science journals.

Nature Strategy Reports

Nature Strategy Reports gives you simple insights to support decisions that impact your organisation

The reports created for you by our subject matter experts combine compelling insights with Nature’s trust and authority. Get an in-depth analysis of your and your peers’ research performance, including a breakdown of relative strengths and weaknesses. All of which is crafted using data and tools from across Nature Research Intelligence, covering all major disciplines and all regions of the world.

Get started

Collaboration

Date range: 1 August 2022 - 31 July 2023

International vs. domestic collaboration by Share

  • 29.54% Domestic (48 institutions)
  • 70.46% International (129 institutions)

Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators with Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) by Share*

  1. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and University of Lille Nord de France (0.24)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)0.04
    University of Lille Nord de France0.19
  2. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and Centre Hospitalier Universitaire de Lille (CHU Lille) (0.15)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)0.04
    Centre Hospitalier Universitaire de Lille (CHU Lille)0.11
  3. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and Assistance Publique-Hôpitaux de Paris (AP-HP) (0.13)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)0.04
    Assistance Publique-Hôpitaux de Paris (AP-HP)0.08
  4. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and Brain and Spine Institute (ICM) (0.09)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)0.04
    Brain and Spine Institute (ICM)0.05
  5. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and National Institute for Health and Medical Research (INSERM) (0.09)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)0.04
    National Institute for Health and Medical Research (INSERM)0.05
  6. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and French National Centre for Scientific Research (CNRS) (0.08)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)0.04
    French National Centre for Scientific Research (CNRS)0.04
  7. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and Impact de l'Environnement Chimique sur la Santé Humaine (IMPECS) (0.08)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)0.03
    Impact de l'Environnement Chimique sur la Santé Humaine (IMPECS)0.05
  8. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and Pasteur Institute (0.07)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)0.04
    Pasteur Institute0.02
  9. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and Centre d’Investigation Clinique (CIC) 1436 (0.06)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)0.03
    Centre d’Investigation Clinique (CIC) 14360.03
  10. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and Sorbonne University (0.06)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)0.04
    Sorbonne University

Top 10 international collaborators with Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) by Share*

  1. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and UCL (0.30)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)0.04
    UCL0.26
  2. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and Western University (UWO) (0.16)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)
    Western University (UWO)0.15
  3. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and University of Toronto (U of T) (0.14)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)0.04
    University of Toronto (U of T)0.10
  4. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and University of Coimbra (UC) (0.12)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)0.04
    University of Coimbra (UC)0.08
  5. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and University of California, San Francisco (UCSF) (0.11)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)
    University of California, San Francisco (UCSF)0.11
  6. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and Mayo Clinic (0.11)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)
    Mayo Clinic0.10
  7. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) (0.11)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)
    Scientific Institute for Research, Hospitalization and Healthcare (IRCCS)0.09
  8. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and University of Lisbon (ULISBOA) (0.10)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)0.04
    University of Lisbon (ULISBOA)0.06
  9. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and August Pi i Sunyer Biomedical Research Institute (IDIBAPS) (0.10)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)0.04
    August Pi i Sunyer Biomedical Research Institute (IDIBAPS)0.06
  10. Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) and Ulm University (0.10)
    Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND)0.04
    Ulm University0.05

*Share is the fractional count allocated to an institution for an article that takes into account the percentage of authors from that institution and the number of affiliated institutions that contributed to the article. The horizontal stacked bar charts above indicate the Share contributed by each institution in the bilateral collaboration. If the Share is not shown, hover over the bar to display it.

Nature Careers

Need to hire scientific researchers?

Nature Careers is visited by over 180,000 active jobseekers per month that you can target directly with your role. Application response rates have increased by 28% on average over 2022 averages.

Relationships

Partner Institutions

Lille Centre of Excellence for Neurodegenerative Disorders (LiCEND) is a research collaboration whose article contributions are accrued to its participating partner institutions below.


Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.